Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00158457
Status:
COMPLETED
Last Update Posted:
2007-07-03
First Post:
2005-09-08
Brief Title:
Simple Once Daily Triple Regimen Including Tenofovir Emtricitabine and Efavirenz in HIV-1 Infected Patients ANRS 1207
Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Organization:
French National Agency for Research on AIDS and Viral Hepatitis
Study Overview
Official Title:
Pilot Trial to Evaluate the Efficacy and Tolerance of a Simple Once Daily Combined Regimen Including Tenofovir TDF Emtricitabine FTC and Efavirenz EFV in HIV-1 Infected Patients Naive to Prior Antiretroviral Treatment in Senegal
Status:
COMPLETED
Status Verified Date:
2007-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In the context of Sub-saharian Africa this trial evaluate one of the most simple treatment available for HIV-1 infected patients The combination proposed is a triple antiretroviral therapy with only one intake of 3 pills per day This combination has already been studied in the North countries
Here in Senegal the efficacy and the compliance to treatment will be evaluated after 24 48 and 96 weeks of treatment
Here in Senegal the efficacy and the compliance to treatment will be evaluated after 24 48 and 96 weeks of treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| IMEA 025 | None | None | None |